168 related articles for article (PubMed ID: 35596661)
21. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
22. [Survival and the value of adjuvant chemotherapy in esophageal squamous cell carcinoma patients with lymphatic metastasis].
Qi Z; Wang YX; Yang Q; Li J; Yao JF; He M
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):628-633. PubMed ID: 28835088
[No Abstract] [Full Text] [Related]
23. Primary mucoepidermoid carcinoma of the esophagus.
Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
25. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
[TBL] [Abstract][Full Text] [Related]
26. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
27. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
Zhang G; Wu B; Wang X; Li J
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
[TBL] [Abstract][Full Text] [Related]
28. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer.
Hu K; Kang N; Liu Y; Guo D; Jing W; Lu J; Tan T; Lv C; Deng Y; Long J; Wang R; Yu J
Cancer Sci; 2019 Feb; 110(2):717-725. PubMed ID: 30467921
[TBL] [Abstract][Full Text] [Related]
29. Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the Surveillance, Epidemiology, and End Results (SEER) database.
Chen Y; Tu J; Zhou S; Fu J; Wang Q
Int J Colorectal Dis; 2021 Apr; 36(4):745-756. PubMed ID: 33415449
[TBL] [Abstract][Full Text] [Related]
30. Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement.
Chung TR; Kim JH; Lee IJ; Cho Y; Kim JW; Lee CG; Jung DH; Park JJ; Youn YH; Park H
Dig Liver Dis; 2019 Nov; 51(11):1610-1616. PubMed ID: 31175014
[TBL] [Abstract][Full Text] [Related]
31. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
32. Prognostic evaluation of esophageal cancer patients with stages I-III.
Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
[TBL] [Abstract][Full Text] [Related]
33. Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?
Situ D; Wang J; Lin P; Long H; Zhang L; Rong T; Ma G
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):45-51. PubMed ID: 23490249
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery.
Zhang D; Zheng Y; Wang Z; Huang Q; Cao X; Wang F; Liu S
Eur J Surg Oncol; 2017 Oct; 43(10):1949-1955. PubMed ID: 28716377
[TBL] [Abstract][Full Text] [Related]
35. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
Shafqat H; Ali S; Salhab M; Olszewski AJ
Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
[TBL] [Abstract][Full Text] [Related]
36. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
37. Bone metastasis in esophageal adenocarcinoma and squamous cell carcinoma: a SEER-based study.
Qin Y; Mao J; Liang X; Wang N; Yuan M; Zhu J; Wu D; Wang Q
Gen Thorac Cardiovasc Surg; 2022 May; 70(5):479-490. PubMed ID: 35044634
[TBL] [Abstract][Full Text] [Related]
38. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
39. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis.
Dubecz A; Gall I; Solymosi N; Schweigert M; Peters JH; Feith M; Stein HJ
J Thorac Oncol; 2012 Feb; 7(2):443-7. PubMed ID: 22173700
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]